MIM
IR icon

MetLife Investment Management’s Ingersoll Rand IR Stock Holding History

MetLife Investment Management’s Portfolio IR Stock Details IR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.73M Sell
82,045
-1,800
-2% -$139K 0.03% 512
2026
Q1 		$6.72M Sell
83,845
-2,967
-3% -$262K 0.03% 502
2025
Q4 		$6.88M Sell
86,812
-3,623
-4% -$286K 0.03% 480
2025
Q3 		$7.47M Sell
90,435
-12,368
-12% -$1.01M 0.04% 464
2025
Q2 		$8.55M Sell
102,803
-1,845
-2% -$145K 0.05% 369
2025
Q1 		$8.37M Sell
104,648
-2,027
-2% -$177K 0.05% 393
2024
Q4 		$9.65M Buy
106,675
+1,761
+2% +$175K 0.05% 268
2024
Q3 		$10.3M Sell
104,914
-2,692
-3% -$250K 0.06% 255
2024
Q2 		$9.77M Buy
107,606
+12,830
+14% +$1.18M 0.06% 250
2024
Q1 		$9M Sell
94,776
-3,485
-4% -$298K 0.06% 259
2023
Q4 		$7.6M Sell
98,261
-1,767
-2% -$121K 0.05% 292
2023
Q3 		$6.37M Sell
100,028
-2,646
-3% -$176K 0.05% 317
2023
Q2 		$6.71M Sell
102,674
-1,846
-2% -$109K 0.05% 323
2023
Q1 		$6.08M Sell
104,520
-1,252
-1% -$70.6K 0.04% 350
2022
Q4 		$5.53M Sell
105,772
-1,305
-1% -$66.6K 0.04% 379
2022
Q3 		$4.63M Sell
107,077
-2,280
-2% -$107K 0.04% 444
2022
Q2 		$4.6M Sell
109,357
-1,255
-1% -$57.1K 0.04% 470
2022
Q1 		$5.57M Buy
110,612
+20,561
+23% +$1.1M 0.04% 456
2021
Q4 		$5.57M Sell
90,051
-1,461
-2% -$83.2K 0.05% 354
2021
Q3 		$4.61M Buy
91,512
+4,962
+6% +$253K 0.04% 406
2021
Q2 		$4.22M Sell
86,550
-2,264
-3% -$111K 0.04% 477
2021
Q1 		$4.37M Sell
88,814
-1,458
-2% -$67.5K 0.04% 463
2020
Q4 		$4.11M Sell
90,272
-3,838
-4% -$159K 0.04% 442
2020
Q3 		$3.35M Buy
94,110
+3,679
+4% +$123K 0.04% 480
2020
Q2 		$2.54M Buy
90,431
+1,230
+1% +$34.7K 0.03% 609
2020
Q1 		$2.21M Buy
+89,201
New +$2.83M 0.03% 570
2019
Q2 		– Sell
-519
Closed -$14.6K – 2519
2019
Q1 		$14.6K Buy
519
+347
+202% +$8.73K ﹤0.01% 2468
2018
Q4 		$3.52K Buy
172
+26
+18% +$638 ﹤0.01% 2496
2018
Q3 		$4.14K Buy
+146
New +$4.09K ﹤0.01% 2549

Other funds holding IR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

MetLife Investment Management's IR Position: Q2 2026 in Review

MetLife Investment Management reduced its Ingersoll Rand (IR) stake by 2.1% in Q2 2026, selling an estimated $139K and leaving 82,045 shares worth $6.73M. The position accounts for 0.03% of the portfolio, ranked #512.

MetLife Investment Management first reported a position in IR in Q3 2018 and has held it in 29 quarters since. The position peaked at $10.3M in Q3 2024. 892 funds tracked by Wall St. Rank hold IR as of Q2 2026.

  • MetLife Investment Management held 82,045 shares of Ingersoll Rand worth $6.73M as of Q2 2026.
  • MetLife Investment Management sold 1,800 Ingersoll Rand shares in Q2 2026, an estimated $139K.
  • Ingersoll Rand made up 0.03% of MetLife Investment Management's portfolio in Q2 2026, its #512 holding.
  • MetLife Investment Management first reported a position in Ingersoll Rand in Q3 2018 and has held it in 29 quarters since.
  • MetLife Investment Management's Ingersoll Rand position peaked at $10.3M in Q3 2024.
  • 892 funds tracked by Wall St. Rank held Ingersoll Rand as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.